
We see Allergy": Direct allergy diagnostics by lable-free visualisition of the patients allergic response. Allergios is developing an AI-powered microfluidic platform for functional allergy diagnostics, aiming to replace risky and resource-intensive oral provocation tests (e.g, DBPCFC) with a cell-based blood test that analyzes individual immune responses to allergens. The platform combines digital holography, cellular immunoassays, and machine learning, targeting a fast-growing global diagnostics market.
Annual Revenue$1M to $5M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.